Get started
QS V3 ORCL Weekly Momentum Breakout AlertORCL (QS V3 Weekly | 2025-11-24) Direction: BUY CALLS Confidence: 60% Expiry: 2025-11-28 (4 days) Strike Focus: $192.50 Entry Range: $9.20 – $9.65 (mid: $9.43) Target 1: $15.10 Stop Loss: $5.66 Weekly Momentum: Bullish (+1.82% 1W) Flow Intel: Neutral Risk Level: ⚠️ Moderate Risk Katy AI Forecast: Predicts move toward $233.28 (+16.7%) by Nov 26–27, with peak near $247. Support: $196.87 Resistance: $234.75 VWAP: $205.75 Volatility: VIX 23.43 Recommended Position Size: 3%
NYSE:ORCLLong
by quantsignals
INTC Weekly Breakout Signal – QS V3 Predicts Bullish UpsideINTC (QS V3 Weekly | 2025-11-24) Direction: BUY CALLS Confidence: 58% Expiry: 2025-11-28 (4 days) Strike Focus: $35.00 Entry Range: $0.73 – $0.80 (mid: $0.77) Target 1: $1.24 Stop Loss: $0.56 Weekly Momentum: Neutral (+0.90% 1W) Flow Intel: Neutral Risk Level: 🔴 High Risk — use small size Katy AI Forecast: Predicts move toward $37.95 (+8.74%) within 48 hours. Resistance: $36.68 Support: $34.38 Volatility: VIX 23.43 (low-moderate) Recommended Position Size: 2%
NASDAQ:INTCLong
by quantsignals
HCA Healthcare I observe a clear rotation of capital into the healthcare sector, with strong inflows toward medical companies reporting solid earnings and outlooks. Within this rotation, HCA Healthcare appears to be the most attractively valued company, supported by consistent profitability, a strong balance sheet, and long-term growth prospects. I consider HCA a high-quality name positioned to benefit from the current shift in market focus toward fundamental strength and stability. I'll play this with a call spread to collect some premium due to the bid prices on these calls...
NYSE:HCALong
by OssianH
REGENXBIO Breakout of descending channelREGENXBIO NASDAQ:RGNX is gearing up for a big move on its daily chart after holding strong within a multi-month ascending channel. The price action recently pulled back from the top of the channel and has now broken out of a short-term descending channel, indicating that buyers are starting to regain control. The stock is currently sitting right on top of the middle mid-range of the larger ascending channel, which is a key pivot point for a continuation of the rally. If NASDAQ:RGNX can hold this breakout and make a solid move higher, the next major target is that top channel resistance near $14.72.
NASDAQ:RGNXLong
by ledgerdary
Meta Platforms (META) – Strong Reaction at Key Demand ZoneMETA has retraced sharply and is now testing a major demand zone around 600 – 585, aligned with the 0.236 Fibonacci level (597). This area represents the first strong support after the recent corrective wave. The latest candles show early signs of buyer interest, suggesting that the market may attempt a rebound if this zone continues to hold. If META confirms support here, the next upside levels are: 637 (0.333 Fib) 665 (0.4 Fib) 707 (0.5 Fib) 749 – 755 (0.618 Fib) 811 (0.75 Fib) A daily close below 585 would signal further weakness and expose the next downside level near 561 (0.15 Fib). As long as the demand zone holds, the bullish recovery scenario remains valid, with the long-term target set at 916.23.
NASDAQ:METALong
by adham2022
Saylor’s Company Is at the Center of a Global Index Shock📉 MSCI vs Strategy: Why Michael Saylor’s Company Is at the Center of a Global Index Shock — And What It Means for Bitcoin Over the past few weeks, one of the most important developments for both equities and crypto has quietly unfolded: MSCI, the world’s largest index provider, has started questioning whether Strategy (formerly MicroStrategy) should continue to be included in its global equity indices. This is not a small technical issue. This is a structural threat with potentially billions of dollars in forced selling, massive volatility for Strategy’s stock, and real implications for Bitcoin’s price trajectory. Here’s the complete breakdown 👇 🔍 What Triggered the MSCI Review? MSCI launched a consultation on how to treat companies that keep the majority of their balance sheet in digital assets (mainly Bitcoin). They call these firms: ► Digital Asset Treasury Companies (DATs) Strategy currently sits at the top of this category with over 200,000 BTC on its books. MSCI’s concern is simple: > “Is Strategy still an operating software company, or has it effectively become a Bitcoin investment vehicle?” If it is considered “fund-like,” it may no longer qualify for inclusion in traditional equity indices. 💥 Why This Matters MSCI’s global indices are tracked by trillions of dollars in passive funds. If Strategy is removed: ► Passive funds must sell Strategy ► Estimated forced selling: $2.8B – $8.8B ► This could trigger a violent liquidity shock in the stock JPMorgan has already warned of large, inevitable outflows if MSCI finalizes the removal. Timeline: Consultation ends: Dec 31, 2025 Decision: Jan 15, 2026 Implementation: Feb 2026 index rebalance This is now one of the most significant upcoming market catalysts for both Strategy’s stock and Bitcoin. 🧩 How This Impacts Strategy Stock (STRAT / MSTR) The possible outcomes: 1. MSCI Removes Strategy (Bearish Scenario) Forced selling by index funds Stock drops 35–60% Capital raising becomes harder Leverage strategy weakens Narrative shifts from “corporate Bitcoin champion” to “deindexed crypto proxy” This is the worst-case scenario for Strategy shareholders. 2. MSCI Keeps Strategy but Reclassifies (Neutral Scenario) Some hedging, light selling Stock dips 10–20% But no structural damage Market adjusts and stabilizes 3. MSCI Fully Accepts Strategy (Bullish Scenario) Relief rally Stock jumps 20–40% Strategy strengthens its identity as the “corporate Bitcoin standard” Major buying flows from passive funds This would be a massive validation for Saylor’s Bitcoin-centric business model. ₿ How This Affects Bitcoin Strategy has become a de facto synthetic Bitcoin ETF: Stock rises → Strategy borrows more → buys more BTC Stock falls → borrowing becomes expensive → Bitcoin buying slows A deep crash → market fears forced BTC selling Under bearish MSCI outcome: BTC likely drops 5–15% on fear Leverage unwinds Sentiment weakens temporarily Under bullish MSCI outcome: BTC gains 3–7% Institutional confidence strengthens More corporates may consider a Bitcoin treasury strategy 🔄 The Reflexive Feedback Loop At the heart of this story is a powerful feedback loop: Strategy stock → borrowing capacity → BTC accumulation → stock valuation → investor demand MSCI’s decision can break or accelerate this loop. This is why the market is watching this event very carefully. 📊 Quick Summary Table MSCI Outcome Strategy Stock Bitcoin Sentiment ❌ Remove –35% to –60% –5% to –15% Fear ⚠️ Reclassify –10% to –20% –1% to –3% Neutral ✔️ Keep +20% to +40% +3% to +7% Bullish 🧠 Final Thoughts Whether you’re a Bitcoin investor or an equity trader, this MSCI review is far more than a technical classification issue. It is a macroeconomic event that could: Move billions in passive capital Impact the largest corporate Bitcoin holder Shape the future of Bitcoin treasury strategies Affect volatility across BTC, NASDAQ, and crypto markets The coming months will decide whether Strategy becomes: ⚡ A globally recognized corporate-Bitcoin pioneer, or ⚠️ A de-indexed, fund-like crypto vehicle under regulatory pressure. Either way, this is one of the most important long-term catalysts to watch.
NASDAQ:MSTR
by CmpCryptoInsights
ANNX 1D - pennant before the next impulse?On the daily chart, Annexon Inc. is forming a bullish pennant after a strong upward move — a classic continuation pattern often signaling the next wave of momentum. The price remains above the 50-day and 200-day moving averages, with a golden cross confirming that buyers are still in control. The key support zone is $2.70–2.90, while Fibonacci targets sit at $4.29 and $5.69 if momentum continues. From a fundamental view , Annexon stays on investors’ radar as it develops treatments for neurodegenerative disorders - a risky but high-potential biotech niche. Tactical plan: wait for a confirmed breakout from the pennant. If buyers push through, the uptrend could accelerate fast. Remember - a golden cross doesn’t always mean golden profits, but it might this time.
NASDAQ:ANNXLong
by TotoshkaTrades
JOHNSON & JOHNSON Short-term correction ahead.Johnson & Johnson (JNJ) has been trading within a 5-month Channel Up since the June 20 Low, with the 1D MA50 (red trend-line) in firm Support. The 4H RSI is printing a peak formation similar to all previous Higher Highs of the pattern. What followed after all those tops were pull-backs just under the 0.382 Fibonacci retracement level but never below the 1D MA50. As a result, we expect a technical pull-back (Bearish Leg) on this stock to $197.50. --- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** --- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:JNJShort
by TradingShot
Amd Gap Trade IdeaHello TradingView Community! Hope everyone is doing great and navigating this market with confidence. Sharing a fresh technical observation on AMD, which is now approaching a very interesting zone. Let’s dive into the detail. 🔹AMD – Critical Technical Crossroad as Price Sits Inside the Gap Zone--:: AMD is currently trading inside a major gap zone, an area that previously attracted strong institutional buying. With the price now resting near the $204 support, the stock has moved into a region where market psychology and liquidity dynamics tend to play a decisive role. This zone often dictates whether buyers regain control or whether sellers extend their dominance. A clear Lower-Highs trendline has formed above the current price, signaling that sellers are stepping in at progressively lower levels. Another touch on this descending trendline would further validate it as a strong resistance a level that could shape AMD’s next directional move in the short term. 🔹Why This Zone Matters--:: Gaps are areas of low liquidity, and once breached, the price often travels quickly through them. AMD is sitting right inside such a pocket, making this structure highly reactive. Recent volume expansion on the decline shows that market participants are actively positioning ahead of a potential breakout or breakdown. If the gap fails to hold, the next major downside magnet lies around the $151 base support, a historically strong demand area that absorbed selling pressure in the past. These technical elements combined make this a highly sensitive and high-impact region for the stock. 🔹Bullish Setup--:: If buyers successfully defend the $204 zone and regain momentum, AMD may bounce toward the descending trendline. A strong breakout above that trendline would shift short-term sentiment toward the bulls and potentially invite fresh momentum trades targeting higher levels. 🔹Bearish Setup--:: A sustained breakdown below the gap zone would expose the stock to deeper downside toward the $151 support. This level is likely to act as a stronger reaction point where long-term buyers could step back in. 🔹Conclusion--:: AMD is at a critical decision point where both bulls and bears are preparing for the next big move. The combination of a major gap, a tightening trendline, and expanding volume makes this setup especially important to monitor. The next few sessions could reveal a volatile and directional move, and traders who stay alert to these key levels will have the upper hand. Regards- Amit.
NASDAQ:AMDShort
by AMIT-RAJAN
1
Technical Analysis On $IREN: A Potential Reversal in the MakingThe technical structure for this asset is exhibiting compelling signs that a significant low may be forming, suggesting the prolonged downtrend could be exhausting and a reversal phase may be underway. The convergence of key Fibonacci levels and emerging bullish signals creates a narrative worthy of close attention. 1. The Macro View: A Likely Bottom Formation The assessment that the asset has "most likely bottomed" is based on key technical behaviors. This typically involves a period of price consolidation at lower levels, a slowing of downward momentum (as indicated by potential bullish divergences on oscillators like the RSI or MACD), and a clear rejection of further lows. This price action suggests that selling pressure is drying up and a new equilibrium is being established, providing a foundation for a potential new upward cycle. 2. The Fibonacci Framework: A Roadmap for the Reversal Fibonacci retracement levels, applied to the most recent significant downtrend, provide a mathematical roadmap for identifying potential support, entry zones, and profit targets. Primary Support (The 0.5 Fibonacci Level - $41): This level at $41 has acted as a critical foundation. The successful defense of this 0.50 retracement level is a strong technical sign. It represents a key psychological midpoint where buyers have historically stepped in with force, preventing further decline and solidifying this zone as the primary support floor for the new bullish thesis. A break below this level would seriously challenge the bottoming narrative. Buy Zone (The 0.382 Fibonacci Level - $49.47): The $49.47 level is identified as a strategic accumulation zone. In a recovering market, prices often pull back to retest former resistance levels, which then turn into new support. A successful retest of the 0.382 level at $49.47, where the price touches this area and bounces, would offer a high-confidence entry point with a well-defined risk level just below the primary $41 support. 3. Profit-Taking Strategy and Emerging Signals Take-Profit Targets: The initial recovery move has two clear technical objectives. Initial Target: $55. This represents the first significant resistance zone where some profit-taking can be expected. Extended Target: $59. A break above $55 opens the path to this more substantial target, which likely aligns with a previous swing high or a key Fibonacci extension level. Potential Buy Signal (Blue Vertical Lines): Your observation of the "blue vertical lines" indicating a potential buy signal is crucial. This typically refers to a specific trigger from a momentum oscillator or a proprietary indicator. This signal adds a layer of confirmation, suggesting that not only is the price at a supportive level, but the underlying momentum is also shifting from bearish to bullish. This alignment between price (Fibonacci level) and momentum (buy signal) significantly strengthens the case for a sustainable upward move. Synthesis and Strategic Outlook The technical picture suggests the asset is in the early stages of a potential trend reversal. The Bullish Narrative: The bottom appears to be in at the $41 (0.50 Fib) support. The strategy is to look for entry opportunities, ideally on a pullback towards the $49.47 (0.382 Fib) buy zone, especially if it coincides with a confirmed buy signal from your indicator (the blue vertical lines). The subsequent targets are $55 and $59. Risk Management: The entire bullish thesis depends on the asset holding above the $41 support. A decisive break below this level would invalidate the bottoming premise and call for a re-evaluation. In summary, patience is key. The setup is promising, but waiting for the price to interact with the defined buy zone and for confirming signals to align will provide a much higher-probability entry for the anticipated move toward the $55 and $59 targets.
NASDAQ:IRENLong
by KalaGhazi
Breaking: Enlivex Therapeutics (NASDAQ :ENLV) Spike 44% Today Enlivex Therapeutics Ltd. (ENLV) Spike 44% albeit market dip. The asset broke through the $0.85 support point to reclaim the $1 resistant. With the RSI at 72, the asset is poised for a bullish continuation pattern should the share price break though the $1.30 resistant setting the pace to reclaim the $2 resistance point. In another news, Enlivex Therapeutics Ltd. (NASDAQ: ENLV) today announced the appointment of Mr. Matteo Renzi, former Prime Minister of Italy, to the board of directors at Enlivex, effective November 24th. 2025. Similarly, Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation. Analyst Summary According to 2 analysts, the average rating for ENLV stock is "Buy." The 12-month stock price target is $7.0, which is an increase of 442.64% from the latest price. About ENLV Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis.
NASDAQ:ENLVLong
by DEXWireNews
SharpLink & the Rise of Crypto Treasury CompaniesA quiet but profound shift is taking hold in public markets: companies like SharpLink NASDAQ:SBET , MicroStrategy NASDAQ:MSTR , and a fast-growing list of others are no longer just operating businesses; they are transforming into full-fledged on-chain corporate treasuries.They have virtually no direct competitors. Their true goal isn’t to outdo one another, but to accumulate massive Ethereum reserves, lock them into staking and restaking protocols, earn high-yield passive income, and simultaneously lay the foundation for an entirely new corporate finance stack. From Proof-of-Work to Proof-of-Stake and Restaking Bitcoin remains tied to energy-intensive mining. Ethereum, Solana, TON, and nearly every major Layer-1 have moved to Proof-of-Stake, where token holders secure the network and earn rewards. Standard staking yields ~3–5 % annually. Restaking protocols like EigenLayer reuse the same locked ETH to secure additional networks, pushing effective yields into the 8–15 %+ range while keeping the assets liquid through derivatives. The New Corporate Treasury Model SharpLink and its peers are building treasuries that live entirely on-chain. They raise U.S. dollars through equity offerings or low-cost convertible debt, immediately convert those dollars into Ethereum, and lock the tokens into staking and restaking layers. On October 28, SharpLink announced it would deploy another $200 million into restaking protocols. Today, the company’s primary revenue and profit driver is no longer its legacy operations; it’s staking and restaking rewards on its Ethereum holdings. In its most recent third quarter, SharpLink reported over $100 million in net income almost exclusively from these activities. Why the Model Is Spreading So Fast Capital can be raised at 3–4 % cost and deployed into strategies yielding significantly more, with virtually no duration mismatch. Every new corporate treasury that stakes its ETH reduces circulating supply and steadily tames realized volatility. By 2026–2027, traditional giants like JPMorgan and BlackRock are widely expected to accept liquid staking tokens (stETH and equivalents) as high-grade collateral alongside BTC and ETH. Once that happens, public companies will be able to earn double-digit risk-adjusted returns on their balance sheets without ever losing access to the underlying assets. The Bigger Picture These companies aren’t competing; they are collectively building the rails of tomorrow’s corporate finance system, one staked token at a time. 5-10 years, possibly much sooner - and holding staked Ethereum on a public company’s balance sheet will feel as normal as holding cash or short-term Treasuries does today. SharpLink and the handful of aggressive first-movers are not just speculating on price. They are positioning themselves as the foundational infrastructure of the next financial era, when corporate balance sheets migrate en masse onto the blockchain. Disclosure : Cryptocurrency investments remain highly volatile and unregulated in many jurisdictions. Always conduct your own research and invest only what you can afford to lose.
NASDAQ:SBETLong
by juliakhandoshko
1
BABA Breakout WatchBABA’s daily chart has shifted from a strong August–October rally into a corrective phase, with price now around 160 and printing a clear sequence of lower highs and lows. Price sits below the MA20 and MA60 but still above the rising MA120 near 141. This keeps the broader uptrend technically alive while short-term pressure remains bearish. A potential Double Bottom is developing in the 150–153 demand zone, with a strong bullish reaction from the second trough and a neckline around 168. For bulls, the key is clearing the moving-average “ceiling” first. A daily close above 165 would show that buyers are absorbing supply at resistance and open the path toward a retest of the 168 neckline. A confirmed daily close above 168 would validate the Double Bottom and put 175–179 initially, and then 184, on the radar as measured-move targets. For this bullish idea, a sustained move back below 158, and especially a break under 150, would be a clear invalidation and shift focus back toward 148–144 near the MA120. If price instead loses 158 on a daily close without ever reclaiming 165, the bounce looks more like a relief rally inside the downtrend, with sellers likely pressing for a deeper test of 150 and potentially 144. Until either 165 breaks topside or 158 fails, expect noisy consolidation between support at 150 and resistance near 165. This is a study, not financial advice. Manage risk and invalidations. Thought of the Day 💡: Let the level confirm the idea, not the other way around. ------------------------ Thanks for your support! If you found this idea helpful or learned something new, drop a like 👍 and leave a comment, I’d love to hear your thoughts!
NYSE:BABALong
by bbqgio